Quarterly Report - Q4 FY26
Filed with ASX · · 10 pages · English
Summary by 6ix AI
The report highlights the signing of a term sheet with Gleneagles Hospital Hong Kong, enhancing access to clinical environments for Nexsen's diagnostic devices. Overall, the filing outlines Nexsen's progress in commercial readiness and strategic partnerships aimed at facilitating the adoption of its rapid diagnostics technology across Asia-Pacific.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Nexsen
- $1.5m non-dilutive ARC funding for manufacturing
- Nexsen secures first hospital partner in Asia
- Nexsen and Universiti Malaya launch joint facility
- Quarterly Report - Q3 FY26
- QMS milestone achieved
Later from Nexsen
- Annual Report - FY 2026
- Trading Halt
- Suspension from Quotation
- Reinstatement to Quotation
- Quarterly Report - Q1 FY27
Follow Nexsen into a list and get an email when it puts out news.
Follow Nexsen